LOGC
LogicBio Therapeutics, Inc. Common Stock
LOGC
LOGC
Delisted
LOGC was delisted on the 15th of November, 2022.
61 hedge funds and large institutions have $128M invested in LogicBio Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
Holders
61
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$807K | |
| 2 | +$718K | |
| 3 | +$607K | |
| 4 |
BlackRock
New York
|
+$585K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$176K |
Top Sellers
| 1 | -$628K | |
| 2 | -$451K | |
| 3 | -$324K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$248K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$154K |